ArticleBiomedicines2022

Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors.

Johannes Zellmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.